Premenopausal breast cancers in type 2 diabetics are often aggressive and hormone-receptor-negative, whereas postmenopausal cases are commonly hormone-receptor-positive and influenced by adipose-derived estrogen. The gene discussed is NR4A1; the disease is breast cancer.